Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Cox

Showing results (141-150 of 208) with videos related to

Pageof 21
Sort By:
Clinical Genetics|January 23, 2019
Deep phenotyping of 14 new patients with IQSEC2 variants, including monozygotic twins of discordant phenotypeJessica A Radley, Rory B G O'Sullivan, Sarah E Turton, et al.
Archives of Disease in Childhood|November 5, 2011
Emollients, education and quality of life: the RCPCH care pathway for children with eczemaHelen Cox, Kate Lloyd, Hywel Williams, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2017
Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South AfricaPeter Bock, Karen Jennings, Redwaan Vermaak, et al.
Nature Communications|August 30, 2022
Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian clade toward extensively drug resistant tuberculosisMatthias Merker, Jean-Philippe Rasigade, Maxime Barbier, et al.
Trials|December 3, 2010
Participants' preference for type of leaflet used to feed back the results of a randomised trial: a surveyStephen Brealey, Lazaros Andronis, Laura Dennis, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 9, 2020
Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly and define a novel laminopathyDavid A Parry, Carol-Anne Martin, Philip Greene, et al.
Human Molecular Genetics|April 4, 2017
Localized TWIST1 and TWIST2 basic domain substitutions cause four distinct human diseases that can be modeled in Caenorhabditis elegansSharon Kim, Stephen R F Twigg, Victoria A Scanlon, et al.
The Lancet. Microbe|November 12, 2021
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology studyHelen Cox, Zubeida Salaam-Dreyer, Galo A Goig, et al.
Clinical Medicine (London, England)|February 20, 2024
Extending the reach of expert amyloidosis care: A feasibility study exploring the staged implementation of a UK amyloidosis networkChern Hsiang Choy, Richard P Steeds, Jennifer Pinney, et al.
Human Mutation|October 8, 2009
Widening the mutation spectrum of EVC and EVC2: ectopic expression of Weyer variants in NIH 3T3 fibroblasts disrupts Hedgehog signalingMaria Valencia, Pablo Lapunzina, Derek Lim, et al.
Pageof 21

Showing results (141-150 of 208) with videos related to

Sort By:
Pageof 21
Clinical Genetics|January 23, 2019
Deep phenotyping of 14 new patients with IQSEC2 variants, including monozygotic twins of discordant phenotypeJessica A Radley, Rory B G O'Sullivan, Sarah E Turton, et al.
Archives of Disease in Childhood|November 5, 2011
Emollients, education and quality of life: the RCPCH care pathway for children with eczemaHelen Cox, Kate Lloyd, Hywel Williams, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2017
Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South AfricaPeter Bock, Karen Jennings, Redwaan Vermaak, et al.
Nature Communications|August 30, 2022
Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian clade toward extensively drug resistant tuberculosisMatthias Merker, Jean-Philippe Rasigade, Maxime Barbier, et al.
Trials|December 3, 2010
Participants' preference for type of leaflet used to feed back the results of a randomised trial: a surveyStephen Brealey, Lazaros Andronis, Laura Dennis, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 9, 2020
Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly and define a novel laminopathyDavid A Parry, Carol-Anne Martin, Philip Greene, et al.
Human Molecular Genetics|April 4, 2017
Localized TWIST1 and TWIST2 basic domain substitutions cause four distinct human diseases that can be modeled in Caenorhabditis elegansSharon Kim, Stephen R F Twigg, Victoria A Scanlon, et al.
The Lancet. Microbe|November 12, 2021
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology studyHelen Cox, Zubeida Salaam-Dreyer, Galo A Goig, et al.
Clinical Medicine (London, England)|February 20, 2024
Extending the reach of expert amyloidosis care: A feasibility study exploring the staged implementation of a UK amyloidosis networkChern Hsiang Choy, Richard P Steeds, Jennifer Pinney, et al.
Human Mutation|October 8, 2009
Widening the mutation spectrum of EVC and EVC2: ectopic expression of Weyer variants in NIH 3T3 fibroblasts disrupts Hedgehog signalingMaria Valencia, Pablo Lapunzina, Derek Lim, et al.
Pageof 21